FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166943985> ?p ?o ?g. }

• W3166943985 endingPage "1091" @default.
• W3166943985 startingPage "1083" @default.
• W3166943985 abstract "Anti-Ro-52 antibody positivity might be associated with the presence of interstitial lung disease (ILD) among patients with autoimmune features. However, the clinical significance of isolated anti-Ro-52 positivity (i.e. the presence of anti-Ro-52 antibodies but the absence of anti-Ro-60 antibodies; anti-Ro-52+Ro-60-) in patients with ILD is not clear.This is a prospective and observational study of Chinese ILD patients with isolated anti-Ro-52 positivity. According to their myositis specific antibody (MSA) status, patients were split into groups, and their clinical and radiological features were compared.Of the 158 enrolled patients with ILD and isolated anti-Ro-52 positivity (isolated anti-Ro-52-ILD), there were 130 patients with a positive MSA status and 28 patients with a negative MSA status. Anti-synthetase antibodies (ASAs) were found in 61.5% of patients with MSA+-ILD, and anti-melanoma differentiation associated protein 5 (anti-MDA-5) antibodies were found in the remaining 38.5% of patients. The anti-nuclear antibody (ANA) pattern was associated with ASA and anti-MDA-5 positivity (x2 = 70.7, P < 0.001; Cramer's value 0.47, P < 0.001): ANA negativity was associated with anti-MDA-5 positivity, and cytoplasmic ANA positivity was associated with ASA positivity. There were statistically significant differences in the high-resolution CT patterns between patients with isolated anti-Ro-52 positivity with different MSA statuses (x2 = 29.8, P < 0.001; Cramer's value 0.31, P < 0.001): OP pattern was more common in patients with anti-MDA-5 antibodies than in those without anti-MDA-5 antibodies.Patients with isolated anti-Ro-52-ILD showed high positivity of MSA. Isolated anti-Ro-52 positivity with cytoplasmic ANA positivity was strongly associated with ASA+-ILD, while ANA negativity was associated with anti-MDA-5+-ILD." @default.
• W3166943985 created "2021-06-22" @default.
• W3166943985 creator A5018529492 @default.
• W3166943985 creator A5019390272 @default.
• W3166943985 creator A5025768990 @default.
• W3166943985 creator A5042973046 @default.
• W3166943985 creator A5057742472 @default.
• W3166943985 creator A5064862790 @default.
• W3166943985 creator A5067703584 @default.
• W3166943985 creator A5067992967 @default.
• W3166943985 creator A5075902396 @default.
• W3166943985 date "2021-06-15" @default.
• W3166943985 modified "2023-09-24" @default.
• W3166943985 title "Myositis specific antibodies are associated with isolated anti-Ro-52 associated interstitial lung disease" @default.
• W3166943985 cites W1843007555 @default.
• W3166943985 cites W1985650205 @default.
• W3166943985 cites W2000040082 @default.
• W3166943985 cites W2032228412 @default.
• W3166943985 cites W2032249572 @default.
• W3166943985 cites W2043418710 @default.
• W3166943985 cites W2072542606 @default.
• W3166943985 cites W2098843843 @default.
• W3166943985 cites W2103872903 @default.
• W3166943985 cites W2104077617 @default.
• W3166943985 cites W2109522902 @default.
• W3166943985 cites W2130289080 @default.
• W3166943985 cites W2138771973 @default.
• W3166943985 cites W2139544990 @default.
• W3166943985 cites W2170200935 @default.
• W3166943985 cites W2396711686 @default.
• W3166943985 cites W2403287889 @default.
• W3166943985 cites W2416914730 @default.
• W3166943985 cites W2419582408 @default.
• W3166943985 cites W2507763780 @default.
• W3166943985 cites W2594723614 @default.
• W3166943985 cites W2607771665 @default.
• W3166943985 cites W2610799845 @default.
• W3166943985 cites W2611330109 @default.
• W3166943985 cites W2729029988 @default.
• W3166943985 cites W2761218690 @default.
• W3166943985 cites W2794685813 @default.
• W3166943985 cites W2808724999 @default.
• W3166943985 cites W2920829533 @default.
• W3166943985 cites W2921652873 @default.
• W3166943985 cites W2941930820 @default.
• W3166943985 cites W2954782608 @default.
• W3166943985 cites W2959469982 @default.
• W3166943985 cites W2962896643 @default.
• W3166943985 cites W2966445858 @default.
• W3166943985 cites W3007067717 @default.
• W3166943985 cites W3009137682 @default.
• W3166943985 cites W3009862335 @default.
• W3166943985 cites W3031200339 @default.
• W3166943985 cites W3083943443 @default.
• W3166943985 cites W4362189686 @default.
• W3166943985 doi "https://doi.org/10.1093/rheumatology/keab488" @default.
• W3166943985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34128956" @default.
• W3166943985 hasPublicationYear "2021" @default.
• W3166943985 type Work @default.
• W3166943985 sameAs 3166943985 @default.
• W3166943985 citedByCount "5" @default.
• W3166943985 countsByYear W31669439852022 @default.
• W3166943985 countsByYear W31669439852023 @default.
• W3166943985 crossrefType "journal-article" @default.
• W3166943985 hasAuthorship W3166943985A5018529492 @default.
• W3166943985 hasAuthorship W3166943985A5019390272 @default.
• W3166943985 hasAuthorship W3166943985A5025768990 @default.
• W3166943985 hasAuthorship W3166943985A5042973046 @default.
• W3166943985 hasAuthorship W3166943985A5057742472 @default.
• W3166943985 hasAuthorship W3166943985A5064862790 @default.
• W3166943985 hasAuthorship W3166943985A5067703584 @default.
• W3166943985 hasAuthorship W3166943985A5067992967 @default.
• W3166943985 hasAuthorship W3166943985A5075902396 @default.
• W3166943985 hasConcept C126322002 @default.
• W3166943985 hasConcept C142724271 @default.
• W3166943985 hasConcept C159654299 @default.
• W3166943985 hasConcept C163764329 @default.
• W3166943985 hasConcept C203014093 @default.
• W3166943985 hasConcept C2777543607 @default.
• W3166943985 hasConcept C2777714996 @default.
• W3166943985 hasConcept C2781232998 @default.
• W3166943985 hasConcept C71924100 @default.
• W3166943985 hasConcept C90924648 @default.
• W3166943985 hasConceptScore W3166943985C126322002 @default.
• W3166943985 hasConceptScore W3166943985C142724271 @default.
• W3166943985 hasConceptScore W3166943985C159654299 @default.
• W3166943985 hasConceptScore W3166943985C163764329 @default.
• W3166943985 hasConceptScore W3166943985C203014093 @default.
• W3166943985 hasConceptScore W3166943985C2777543607 @default.
• W3166943985 hasConceptScore W3166943985C2777714996 @default.
• W3166943985 hasConceptScore W3166943985C2781232998 @default.
• W3166943985 hasConceptScore W3166943985C71924100 @default.
• W3166943985 hasConceptScore W3166943985C90924648 @default.
• W3166943985 hasIssue "3" @default.
• W3166943985 hasLocation W31669439851 @default.
• W3166943985 hasLocation W31669439852 @default.
• W3166943985 hasOpenAccess W3166943985 @default.
• W3166943985 hasPrimaryLocation W31669439851 @default.

• next